TESAMORELIN 5 MG

Kalpa Pharmaceuticals Tesamorelin 5 mg – Potent GHRH Analog

Kalpa Pharmaceuticals Tesamorelin 5 mg is a synthetic analog of growth hormone-releasing hormone (GHRH), specifically the full-length GHRH (1-44) sequence with a chemical modification that enhances its resistance to enzymatic degradation. Each 2 mL vial contains 5 mg of lyophilized Tesamorelin, designed for reconstitution in research settings investigating metabolic function, body composition, and growth hormone regulation.

Tesamorelin acts on the pituitary somatotrophs to stimulate endogenous growth hormone release with greater potency and duration than shorter GHRH analogs. For researchers studying visceral adiposity and metabolic parameters, this peptide offers distinct advantages. Explore similar research compounds like Sermorelin 5 mg or Ipamorelin 5 mg.

What Makes Kalpa Pharmaceuticals Tesamorelin Unique?

Tesamorelin contains a trans-3-hexenoic acid modification at the N-terminus, which confers resistance to dipeptidyl peptidase-4 (DPP-4) degradation, resulting in a longer half-life compared to unmodified GHRH (1-44). This modification allows for once-daily administration in research protocols while maintaining biological activity.

For metabolic research, Tesamorelin has been extensively studied for its effects on visceral adipose tissue and metabolic parameters. The 5 mg dosage provides sufficient material for extended research protocols investigating chronic GHRH analog administration. Researchers may also compare Tesamorelin with Sermorelin to evaluate differences between GHRH fragments and full-length analogs.

Benefits of Kalpa Pharmaceuticals Tesamorelin for Research

• ✔ Full-length GHRH (1-44) analog with enhanced stability
• ✔ DPP-4 resistant for extended duration of action
• ✔ 5 mg lyophilized powder for reconstitution flexibility
• ✔ Suitable for subcutaneous administration research
• ✔ Relevant for metabolic and body composition studies

External research on Tesamorelin's mechanisms can be explored via PubMed for peer-reviewed studies.

Product Details

Dosage & Usage Guidelines for Research

Reconstitution Protocol

• ✔ Add 2-3 mL bacteriostatic water to the 5 mg vial
• ✔ Swirl gently; do not shake
• ✔ Store reconstituted peptide at 2-8°C and use within 30 days

The standard reconstitution yields a concentration of approximately 1.67-2.5 mg/mL (1670-2500 mcg/mL). For precise dosing, researchers should calculate based on desired mg per injection volume.

Typical Research Parameters

In animal models, Tesamorelin is often administered at dosages ranging from 1-2 mg per day. Due to its approximately 2-hour half-life, once-daily administration is typical in prolonged studies. Subcutaneous injection is the standard route for systemic absorption research.

• ✔ Subcutaneous injection: 1-2 mg once daily
• ✔ Research models: Dosing typically scaled by body weight
• ✔ Study duration: 4-12 weeks for metabolic and body composition studies

Combination Research

Tesamorelin is often studied in isolation for its effects on GH release and metabolic parameters. However, some protocols combine it with GHRP compounds to evaluate synergistic effects on GH pulsatility. For comprehensive metabolic research, explore our range of MOTS-c 10 mg.

What to Avoid During Research

• ❌ Do not use if the lyophilized cake appears discolored or collapsed
• ❌ Avoid exposure to high heat or direct light
• ❌ Do not mix with strong solvents or extreme pH solutions
• ❌ Avoid repeated freeze-thaw cycles after reconstitution

Lab Testing & Batch Transparency

Lab status

COA pending release

Third-party analytical testing (COA) for Kalpa Pharmaceuticals Tesamorelin 5 mg is currently not yet available. Batch-specific assay data, purity analysis, and verification documentation will be published once released.

Testing Status

Pending

COA Availability

Not yet published

Batch Verification

In progress

Update

Coming soon

Transparency note: Kalpa Pharmaceuticals publishes batch-specific lab reports once analytical testing is completed and verified.

Awaiting COA

Shipping & Product Authenticity

What to Expect

• ✔ Orders are processed after payment confirmation
• ✔ USA Domestic shipping is typically faster when local stock is selected
• ✔ International orders include tracking, though update frequency may vary by destination
• ✔ Multiple warehouses may result in separate shipments when applicable

For complete delivery details, tracking policy, and reshipment terms, please see our Shipping Info page.

Storage Guidelines for Lyophilized Peptides

Store Kalpa Pharmaceuticals Tesamorelin 5 mg lyophilized powder in a cool, dry place away from direct light and moisture. Prior to reconstitution, the unopened vial should be kept at controlled room temperature (15-25°C) or refrigerated (2-8°C) for long-term storage. Do not freeze the lyophilized powder, as this may damage the peptide structure.

After reconstitution with bacteriostatic water, the solution must be stored at 2-8°C (refrigerator) and used within 30 days to maintain peptide integrity. Avoid repeated freeze-thaw cycles. Do not use if the solution appears cloudy or contains particulates, or if the vial seal is compromised.

Keep out of reach of children and unauthorized personnel. Follow standard laboratory safety protocols when handling peptides.

Proper storage conditions help maintain research-grade purity and consistent performance across the product's shelf life.

Frequently Asked Questions